Tuspetinib selected for a prestigious national clinical research program for ability to target broad spectrum of AML and MDS populations…
Independent valuation of PsyLabs values Psyence Biomed’s stake at approximately $2 million, doubling in value Debt-for-equity swap with Psyence Group…
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that COMET-HF (Confirmation of…
-- First in new family of EXPAREL patents -- -- Expands EXPAREL intellectual property and provides protection into 2044 -- PARSIPPANY,…
LAUSANNE, Switzerland, Dec. 2, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field…
ANDOVER, Mass., Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming…
DELRAY BEACH, Fla., Dec. 2, 2024 /PRNewswire/ -- The global AI in precision medicine market is projected to reach USD…
Strategic appointment strengthens the company's technology leadership as it seeks to revolutionize cancer diagnostics BALTIMORE and PALO ALTO, Calif., Dec.…
Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/…
BOSTON, Dec. 2, 2024 /PRNewswire/ -- AG Mednet, a leader in clinical trial workflow and process automation, is excited to announce…